CICC: Maintains a target price of HK$37 for Beautiful Life Health (02373), with a rating of "Outperform."

According to the Wise Finance APP, CICC released a research report stating that it maintains its unchanged net profit forecast for Beautiful Countryside Medical Health (02373) for 2025-2026. The current stock price corresponds to a 20/18x P/E ratio based on the non-GAAP net profit of 2025-2026. It maintains an outperform industry rating and a target price of HK$37, corresponding to a 26/23x P/E ratio based on the non-GAAP net profit of 2025-2026, with a 29% upside potential.